Metformin Eql

Metformin, the active ingredient in Metformin Eql, is a Biguanide presented as an oral tablet for oral use. It is used to improve glycaemic control in adults with type 2 diabetes mellitus and may be prescribed as part of a comprehensive diabetes management plan.

GNH USA supplies Metformin Eql as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Eql belongs to the biguanide class and is employed in the management of disorders related to impaired glucose regulation.

- Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c levels. - Prediabetes: helps normalize fasting glucose and delays progression to overt diabetes. - Metabolic syndrome: enhances insulin sensitivity and may aid in weight management.

Metformin Eql may be associated with a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration in taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe hypoglycaemia: when combined with insulin or secretagogues. - Hepatic dysfunction: elevated liver enzymes. - Skin rash or hypersensitivity: including Stevens‑Johnson syndrome. - Persistent gastrointestinal bleeding. - Acute pancreatitis: very uncommon.

When prescribing Metformin Eql, clinicians should consider several safety factors.

- Renal function: assess eGFR before initiation and periodically thereafter. - Hepatic disease: use with caution in patients with liver impairment. - Alcohol consumption: avoid excessive intake to reduce lactic acidosis risk. - Risk of lactic acidosis: monitor for unexplained fatigue, myalgia, dyspnoea. - Pregnancy and lactation: evaluate benefits versus risks with the prescriber. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin Eql can interact with various medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure, increasing lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Nucleoside reverse transcriptase inhibitors: may potentiate metformin exposure.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Corticosteroids: may increase blood glucose, requiring dose adjustment.